CTLA4 and neoplasm: In mice bearing ~ 100 mm3 B78 tumors, the addition of anti-CTLA-4 causes a decrease in Tregs and an increase in T cell activation [32]; even so, the addition of anti-CTLA-4 failed to improve the anti-tumor response of CpG + OX40.